• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

1429-50-1 (((Ethane-1,2-diylbis(azanetriyl))tetrakis(methylene))tetraphosphonic acid)

1

Identification

((Ethane-1,2-diylbis(azanetriyl))tetrakis(methylene))tetraphosphonic acid ((Ethane-1,2-diylbis(azanetriyl))tetrakis(methylene))tetraphosphonic acid
Name ((Ethane-1,2-diylbis(azanetriyl))tetrakis(methylene))tetraphosphonic acid
Formula C6H20N2O12P4
MW 436.123
CAS No. 1429-50-1
EINECS 215-851-5
Smiles OP(CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O)(O)=O
Synonyms
InChI InChI=1S/C6H20N2O12P4/c9-21(10,11)3-7(4-22(12,13)14)1-2-8(5-23(15,16)17)6-24(18,19)20/h1-6H2,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)
2

Introduction

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB000037812

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways
Target
Research Area
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of ((Ethane-1,2-diylbis(azanetriyl))tetrakis(methylene))tetraphosphonic acid

´╗┐Hazard Symbols : Xi
´╗┐Risk Statements : 36/37/38
Safety Statements : 26-36/37/39
8

Spectral Information

9

Suppliers List

10

Related Products

Other Forms of 1429-50-1

Name CAS No Formula MW

Recommended Compounds in

Name CAS No Formula MW

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

Protocol Reference

13

More Information

((Ethane-1,2-diylbis(azanetriyl))tetrakis(methylene))tetraphosphonic acid

Tags: buy 1429-50-1 IC50 | 1429-50-1 price | 1429-50-1 cost | 1429-50-1 solubility | 1429-50-1 purchase | 1429-50-1 manufacturer | 1429-50-1 research buy | 1429-50-1 order | 1429-50-1 MSDS | 1429-50-1 chemical structure | 1429-50-1 Storage condition | 1429-50-1 molecular weight | 1429-50-1 mw | 1429-50-1 datasheet | 1429-50-1 supplier | 1429-50-1 cell line | 1429-50-1 NMR | 1429-50-1 MS | 1429-50-1 IR | 1429-50-1 solubility | 1429-50-1 Safe information | 1429-50-1 Qc and Spectral Information | 1429-50-1 Clinical Information | 1429-50-1 Clinical Trial | 1429-50-1 Route of Synthesis | 1429-50-1 storage condition | 1429-50-1 diseases and conditions | 1429-50-1 flash point | 1429-50-1 boiling point | 1429-50-1 melting point | 1429-50-1 storage condition | 1429-50-1 brand